Journal of Chromatography A, 1139(1), 130135
Treatment combined with antioxidant and anti-fibrotic drugs to intervene in patients can delay the disease process to a certain extent [14]
It discusses the evidence supporting the use of glucagon-like peptide-1 receptor agonists (GLP-1RA) as potential adjunctive therapy in T1D to reduce weight and improve insulin resistance
Unlike earlier GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) that target a single hormone pathway, or tirzepatide (Mounjaro/Zepbound) that targets two, retatrutide activates three distinct metabolic receptors : GIP, GLP-1, and glucagon
and Wayne, K., Blood iron, glutathione, and micronutrient levels and the risk of oral cancer and premalignancy, NCBI , 2008, vol